Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

被引：236

作者：

Aldoss, Ibrahim ^{[1
]}

Yang, Dongyun ^{[2
]}

Aribi, Ahmed ^{[1
]}

Ali, Haris ^{[1
]}

Sandhu, Karamjeet ^{[1
]}

Al Malki, Monzr M. ^{[1
]}

Mei, Matthew ^{[1
]}

Salhotra, Amandeep ^{[1
]}

Khaled, Samer ^{[1
]}

Nakamura, Ryotaro ^{[1
]}

Snyder, David ^{[1
]}

O'Donnell, Margaret ^{[1
]}

Stein, Anthony S. ^{[1
]}

Forman, Stephen J. ^{[1
]}

Marcucci, Guido ^{[1
]}

Pullarkat, Vinod ^{[1
]}

机构：

[1] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, Dept Hematol & Hematopoiet Cell Transplant, Duarte, CA 91010 USA

[2] City Hope Natl Med Ctr, Dept Informat Sci, Div Biostat, Duarte, CA USA

来源：

HAEMATOLOGICA | 2018年 / 103卷 / 09期

关键词：

CONVENTIONAL CARE REGIMENS; OLDER PATIENTS; AZACITIDINE; AML; RECOMMENDATIONS; DIAGNOSIS; TARGETS;

D O I：

10.3324/haematol.2018.188094

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E404 / E407

页数：4

共 12 条

[1]

[Anonymous], 2017, BLOOD S1

[2] BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies [J].

Bogenberger, J. M. ;

Kornblau, S. M. ;

Pierceall, W. E. ;

Lena, R. ;

Chow, D. ;

Shi, C-X ;

Mantei, J. ;

Ahmann, G. ;

Gonzales, I. M. ;

Choudhary, A. ;

Valdez, R. ;

Camoriano, J. ;

Fauble, V. ;

Tiedemann, R. E. ;

Qiu, Y. H. ;

Coombes, K. R. ;

Cardone, M. ;

Braggio, E. ;

Yin, H. ;

Azorsa, D. O. ;

Mesa, R. A. ;

Stewart, A. K. ;

Tibes, R. .

LEUKEMIA, 2014, 28 (08) :1657-1665

[3] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].

Cheson, BD ;

Bennett, JM ;

Kopecky, KJ ;

Büchner, T ;

Willman, CL ;

Estey, EH ;

Schiffer, CA ;

Döhner, H ;

Tallman, MS ;

Lister, TA ;

LoCocco, F ;

Willemze, R ;

Biondi, A ;

Hiddemann, W ;

Larson, RA ;

Löwenberg, B ;

Sanz, MA ;

Head, DR ;

Ohno, R ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649

[4] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].

Doehner, Hartmut ;

Estey, Elihu ;

Grimwade, David ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Larson, Richard A. ;

Levine, Ross L. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel ;

Sierra, Jorge ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wei, Andrew H. ;

Lowenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2017, 129 (04) :424-447

[5] International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts [J].

Dombret, Herve ;

Seymour, John F. ;

Butrym, Aleksandra ;

Wierzbowska, Agnieszka ;

Selleslag, Dominik ;

Jang, Jun Ho ;

Kumar, Rajat ;

Cavenagh, James ;

Schuh, Andre C. ;

Candoni, Anna ;

Recher, Christian ;

Sandhu, Irwindeep ;

Bernal del Castillo, Teresa ;

Al-Ali, Haifa Kathrin ;

Martinelli, Giovanni ;

Falantes, Jose ;

Noppeney, Richard ;

Stone, Richard M. ;

Minden, Mark D. ;

McIntyre, Heidi ;

Songer, Steve ;

Lucy, Lela M. ;

Beach, C. L. ;

Doehner, Hartmut .

BLOOD, 2015, 126 (03) :291-299

[6] Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia [J].

Fenaux, Pierre ;

Mufti, Ghulam J. ;

Hellstrom-Lindberg, Eva ;

Santini, Valeria ;

Gattermann, Norbert ;

Germing, Ulrich ;

Sanz, Guillermo ;

List, Alan F. ;

Gore, Steven ;

Seymour, John F. ;

Dombret, Herve ;

Backstrom, Jay ;

Zimmerman, Linda ;

McKenzie, David ;

Beach, C. L. ;

Silverman, Lewis R. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :562-569

[7] Azacitidine for the treatment of relapsed and refractory AML in older patients [J].

Itzykson, Raphael ;

Thepot, Sylvain ;

Berthon, Celine ;

Delaunay, Jacques ;

Bouscary, Didier ;

Cluzeau, Thomas ;

Turlure, Pascal ;

Prebet, Thomas ;

Dartigeas, Caroline ;

Marolleau, Jean-Pierre ;

Recher, Christian ;

Plantier, Isabelle ;

Stamatoullas, Aspasia ;

Devidas, Alain ;

Taksin, Anne-Laure ;

Guieze, Romain ;

Caillot, Denis ;

Vey, Norbert ;

Ades, Lionel ;

Ifrah, Norbert ;

Dombret, Herve ;

Fenaux, Pierre ;

Gardin, Claude .

LEUKEMIA RESEARCH, 2015, 39 (02) :124-130

[8] Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia [J].

Konopleva, Marina ;

Pollyea, Daniel A. ;

Potluri, Jalaja ;

Chyla, Brenda ;

Hogdal, Leah ;

Busman, Todd ;

McKeegan, Evelyn ;

Salem, Ahmed Hamed ;

Zhu, Ming ;

Ricker, Justin L. ;

Blum, William ;

DiNardo, Courtney D. ;

Kadia, Tapan ;

Dunbar, Martin ;

Kirby, Rachel ;

Falotico, Nancy ;

Leverson, Joel ;

Humerickhouse, Rod ;

Mabry, Mack ;

Stone, Richard ;

Kantarjian, Hagop ;

Letai, Anthony .

CANCER DISCOVERY, 2016, 6 (10) :1106-1117

[9] Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma [J].

Kumar, Shaji ;

Kaufman, Jonathan L. ;

Gasparetto, Cristina ;

Mikhael, Joseph ;

Vij, Ravi ;

Pegourie, Brigitte ;

Benboubker, Lofti ;

Facon, Thierry ;

Amiot, Martine ;

Moreau, Philippe ;

Punnoose, Elizabeth A. ;

Alzate, Stefanie ;

Dunbar, Martin ;

Xu, Tu ;

Agarwal, Suresh K. ;

Enschede, Sari Heitner ;

Leverson, Joel D. ;

Ross, Jeremy A. ;

Maciag, Paulo C. ;

Verdugo, Maria ;

Touzeau, Cyrille .

BLOOD, 2017, 130 (22) :2401-2409

[10] BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells [J].

Lagadinou, Eleni D. ;

Sach, Alexander ;

Callahan, Kevin ;

Rossi, Randall M. ;

Neering, Sarah J. ;

Minhajuddin, Mohammad ;

Ashton, John M. ;

Pei, Shanshan ;

Grose, Valerie ;

O'Dwyer, Kristen M. ;

Liesveld, Jane L. ;

Brookes, Paul S. ;

Becker, Michael W. ;

Jordan, Craig T. .

CELL STEM CELL, 2013, 12 (03) :329-341

← 1 2 →